RaySearch and Radiology Oncology Systems Forge Partnership for Enhanced Cancer Care Access
Partnership Overview
RaySearch Laboratories AB (publ) and Radiology Oncology Systems, Inc. (ROS) have announced a significant strategic partnership aimed at broadening access to cancer treatment technologies. This collaboration focuses on integrating refurbished linear accelerators with cutting-edge software solutions. This is particularly important as many functional linear accelerators are often discarded after ten years, despite being capable of being refurbished and utilized in centers lacking effective cancer treatment options.
Goals of the Partnership
The primary objective of this alliance is to provide comprehensive solutions that enhance radiation therapy access, ensuring superior quality of care, and bolstering the market positions of both companies. By tapping into the refurbished market, RaySearch and ROS aim to promote sustainability and extend the lifecycle of linear accelerators, thus contributing to environmental stewardship within the healthcare sector. This initiative will facilitate a broader adoption of RaySearch's advanced treatment planning systems, RayStation® and RayCare®.
Market Impact
Since the partnership's inception, both companies have already secured orders from several treatment centers. Notably, agreements have been established with two facilities in Argentina, both equipped with Varian Trilogy™ linear accelerators. In the United States, another center utilizing TrueBeam® and RayStation has joined the collaboration. Moreover, a facility in Mexico is set to implement Elekta Versa HD® alongside RayStation. This demonstrates the immediate global impact of the partnership in expanding access to much-needed cancer care.
Statements from Leadership
John V. Vano, President of Radiology Oncology Systems, highlighted the pressing need for enhanced cancer care opportunities worldwide, noting that there exists a significant gap between patient demand and the availability of advanced technologies. He stated, "Our collaboration with RaySearch allows us to help our customers expand their access to critical, life-changing care."
Johan Löf, founder and CEO of RaySearch, also commented on the partnership's significance. He expressed, "Access to care is critical for us to fulfill our vision of a world where cancer is conquered. This partnership, with its combination of refurbished linacs and advanced software solutions, can truly make a difference."
Benefits of Refurbished Technology
Refurbished linear accelerators not only serve an essential role in treating cancer patients but also represent a sustainable practice within healthcare. By renewing and upgrading these technologies, RaySearch and ROS aim to provide world-class cancer care in regions that may otherwise lack access to high-quality treatment options. This environmentally conscious approach helps reduce waste while simultaneously serving a critical need in the healthcare market.
Conclusion
This partnership between RaySearch and Radiology Oncology Systems marks a pivotal step towards making advanced cancer treatments more accessible to patients globally. With a shared commitment to innovation, sustainability, and patient care, both companies are positioned to revolutionize the landscape of radiation therapy. This combined effort holds the potential to significantly improve the quality of life for countless individuals battling cancer.
For more information, please reach out to Johan Löf, CEO of RaySearch Laboratories at +46 (0) 8 510 530 00 or via email at [email protected]